The Bric countries (Brazil, Russia, India and China) have long been the focus of emerging-market investors. But it is in Africa, a region with the world’s second-fastest growth, where the next big business opportunities lie. In about one-third of the continent’s 55 countries, annual gross domestic product growth is above 6 per cent and Sub-Saharan Africa grew at an estimated 5.1 per cent in 2013. Foreign investors report that their return on investment in Africa is higher than in any other emerging region. By 2040, the continent’s working-age population will total an estimated 1.1 billion people, providing businesses with a larger labour pool than even China or India. Moreover, economic expansion is taking place not just in urban centres, but in small towns and villages as well.
However, Africa also faces major challenges. One of the biggest concerns is inadequate health care. Life expectancy is 14 years below the global average. Nearly one in 20 adults in the 15-49 age group in Sub-Saharan Africa lives with HIV — roughly six times the global average. Every minute, an African child dies from malaria. Non-communicable diseases are projected to become the most common causes of death by 2030. The number of diabetes cases, for example, is expected nearly to double over the next two decades. If left unaddressed, the dual burden of communicable and non-communicable diseases could jeopardise Africa’s economic potential. To avoid this, three critical areas of health care must be addressed: Technology, infrastructure and education.
Africa has witnessed some remarkable technological leaps. A decade ago, telecom infrastructure was almost non-existent. Today, one in six people owns a mobile phone, the benefits of which go far beyond easy communication. Africa has pioneered the use of mobile banking, with local players like M-Pesa and global corporations like Citi demonstrating how new technology can provide vital financial services to the unbanked population. Mobile money and digital wallets accessed on cellphones eliminate the need for physical cash in rural areas, where financial services are limited and carrying large amounts of cash is risky. Joining this mobile-phone revolution, Novartis is working with five African governments and private-sector partners to improve drug distribution and monitor the supply of anti-malaria medicines in rural areas, using text messaging and electronic mapping. Previously, patients would travel to distant clinics, only to find that the medicines they needed were no longer in stock. Now, thanks to the SMS for Life project, vital medicines can be quickly redistributed to where they are most needed.
A second crucial aspect is infrastructure. Good rail lines, roads and ports allow products and services to be distributed widely at lower cost and offer benefits from economies of scale. This is an essential component of any country’s economic development. And nowhere are the benefits more evident than in the provision of health care. Fortunately, several companies are rising to the challenge. Coca-Cola, for example, is contributing its supply-chain expertise to map out health facilities and implement stock-management software to support the distribution of bed nets, contraceptives, anti-Aids drugs and vaccines to remote villages. Meanwhile, Novartis is piloting a “social venture” business model to give poor people in remote villages access to vital medicines that are packaged in small, affordable doses.
The global disease burden
Finally, education is one of the most powerful tools for reducing poverty and generating sustainable, inclusive economic growth. But, given limited resources and few teachers, too many children are being left behind. Public-private partnerships are helping to change this. IT company Cisco, for example, works with non-governmental organisations to connect communities and help students develop skills in information and communications technology. Poor education also affects health. Although Africa accounts for one-seventh of the world’s population, it bears one-quarter of the global disease burden, yet has a mere 2 per cent of the world’s doctors. Unsurprisingly, many health problems stem from ignorance about diseases and basic hygiene. So Novartis has formed a partnership with the Earth Institute, the United Nations and private-sector groups to train and deploy, by 2015, a million community health workers in Sub-Saharan Africa to deliver basic treatment and preventive care and to track disease outbreaks. The idea is that local people will learn how to support their communities, rather than rely on handouts, and thereby lift themselves out of poverty permanently.
Africa is increasingly showing signs of its promise, but innovative solutions to improve its people’s health are essential if the continent is to utilise its true potential. This will require more than philanthropy: It demands new commercial models that solve health-care issues, help the economy grow and benefit those who invest in Africa’s future.
Joseph Jimenez is CEO of Novartis.